Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
09/2004
09/16/2004WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/15/2004EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme
09/15/2004EP1456176A1 Improved compounds for generating chemiluminescence with a peroxidase
09/09/2004US20040176599 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound
09/09/2004US20040176462 NPY Y5 antagonist
09/08/2004CN1526689A Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate
09/01/2004EP1451156A1 4-aminoquinoline compounds
09/01/2004EP1450818A2 A method for treating inflammatory bowel disease
09/01/2004EP1450803A1 New uses for anti-malarial therapeutic agents
08/2004
08/31/2004US6783948 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
08/26/2004US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound
08/25/2004CN1523016A Acridine derivative and its application
08/19/2004WO2004069804A1 Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria
08/12/2004WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/05/2004US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/04/2004EP1076646B1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
07/2004
07/29/2004US20040146746 Diphenyl anthracene derivatives and organic electroluminescent device employing the same
07/29/2004US20040144948 Novel compounds for generating chemiluminescence with a peroxidase
07/28/2004EP1440314A2 Chemiluminescent compounds and use thereof
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/21/2004EP1438288A1 Substituted thioacetamides
07/14/2004CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents
07/14/2004CN1157394C Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds
07/08/2004US20040132747 Novel heteroaryl derivatives and their use as medicaments
07/01/2004WO2004032929A3 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease
07/01/2004US20040126700 Solvent solubility; quality film coatings; workability
06/2004
06/30/2004EP1432734A1 Cytokine receptor
06/29/2004CA2133089C Novel cyclic amino acids and derivatives thereof
06/23/2004EP1430008A2 Process for preparing pentacene derivatives
06/17/2004US20040116445 Substituted thioacetamides
05/2004
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/25/2004US6740756 Fluorescent lanthanide chelates
05/20/2004US20040097530 Novel heteroaryl derivatives and their use as medicaments
05/12/2004EP1015461B1 Novel compounds for generating chemiluminescence with a peroxidase
05/12/2004EP0778947B1 Chemiluminescent detection of hydrolytic enzymes using an acridan
04/2004
04/29/2004US20040082592 Metabotropic glutamate receptor antagonists
04/28/2004CN1492857A Improved compounds for generating chemiluminescence with peroxidase
04/22/2004WO2004032929A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease
04/22/2004CA2501491A1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
04/21/2004EP1411047A1 Intercalators having affinity for DNA and methods of use
04/21/2004EP1409516A2 Aromatic sulfenates for type i phototherapy
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/20/2004US6723851 Acridine derivatives as ?signal molecules? in chemical or biochemical assays
04/15/2004US20040068808 Trichromatic; blue naphthoquinone(2,3-c)acridone dyes
04/14/2004EP0706515B1 Intercalators having affinity for dna and methods of use
04/13/2004CA2276747C Methods and devices for the reduction of small organic compounds from blood products
04/06/2004US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
04/01/2004US20040063147 Novel applications of acridinium compounds and derivatives in homogeneous assays
03/2004
03/31/2004EP1403254A1 Novel applications of acridinium compounds and derivatives in homogeneous assays
03/18/2004US20040053964 N-type calcium channel antagonists for the treatment of pain
03/18/2004US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
03/17/2004EP1397678A1 Luciferin hydrazides
03/17/2004EP1397488A1 Novel compounds for chemiluminescense procedures
03/17/2004CN1482691A Display device with anthracene and triazine derivatives
03/17/2004CN1142146C Fluorescent reagent 2-(N-acridone)-chlorethyl formate
03/16/2004US6706722 Heteroaryl derivatives and their use as medicaments
03/11/2004WO2004020373A1 Spiro compound and organic luminescence device using the same
03/11/2004WO2004020372A1 Fluorene compound and organic luminescent device using the same
03/11/2004WO2004020371A1 Condensed polycyclic compound and organic light-emitting device using the same
03/10/2004CN1481423A Dyeing or printing of maunfactured natural polymer and synthetic hydrophobic fibre materials
03/04/2004WO2004018418A2 Hydrophilic chemiluminescent acridinium labeling reagents
03/04/2004WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
03/04/2004WO2003027050A3 Process for preparing pentacene derivatives
03/03/2004EP1392776A2 Acridone derivatives as labels for fluorescence detection of target materials
03/02/2004US6699891 Npyy5 antagonists
02/2004
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/26/2004US20040038294 Hydrophilic chemilumescent acridinium labeling reagents
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/24/2004US6696569 Compounds for generating chemiluminescence with a peroxidase
02/12/2004US20040029897 Frangible compounds for pathogen inactivation
02/05/2004WO2004011946A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes
02/05/2004US20040023913 Agent with inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof
02/05/2004US20040023409 Reagents and methods that afford direct attachment of the acridine dye reporter to either the N-terminus or C-terminus of a synthetic or recombinant peptide or protein and their derivatives in a site-specific manner
02/05/2004CA2493314A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes
01/2004
01/29/2004US20040018383 Electrolytic cell with anode, cathode and luminescence zones
01/29/2004US20040018380 Display device with anthracene and triazine derivatives
01/28/2004EP1385221A2 Display device with anthracene and triazine derivtives
01/28/2004EP1353908A4 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
01/28/2004CN1136042C Flow device for the reduction of compounds from biological compositions and methods of use
01/22/2004WO2003055447A3 Heterocyclic acridone inhibitors of impdh enzyme
01/14/2004EP1380574A1 9-aminoacridine derivates and process for the preparation thereof
01/14/2004CN1468224A Derivatives of quinoline as alpha-2 antagonists
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer
01/07/2004EP1377554A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
01/02/2004EP1373250A1 Viologen linked acridine based molecule and process for the preparation thereof
01/02/2004EP1373213A1 A process for the synthesis of an annulated pyridine base
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
12/2003
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003038399A3 Chemiluminescent acridinium compounds and their use in an assay to detect analytes
12/31/2003CN1132676C 用于降低血制品中小有机分子的方法和装置 For reducing blood products of small organic molecules method and apparatus
12/30/2003US6670358 Substituted thioacetamides
12/16/2003CA2269547C Process for converting nitrogen-containing hydroxy heteroaromatics to arylamines
12/10/2003EP1369417A1 Acridine derivatives
12/04/2003WO2002099424A3 Acridone derivatives as labels for fluorescence detection of target materials
12/04/2003US20030225078 Derivatives of quinoline as alpha-2 antagonists
11/2003
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003US20030219844 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
11/26/2003EP1364944A1 Frangible Compounds for Pathogen Inactivation
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 22